Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: twt who wrote (623)	11/30/1998 2:26:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 2539

From Nov. 29 Bloomberg Equity Preview: Monsanto Co. (MTC): The agricultural biotechnology company may sell its NutraSweet artificial-sweetener business as part of a restructuring, Crain's Chicago Business reported, citing analysts. The unit is expected to fetch about $800 million, though a Monsanto spokeswoman said the St. Louis-based company hasn't decided which businesses to divest. Monsanto plans to sell off divisions that don't relate directly to its agricultural, drug or nutrition businesses. Monsanto rose 7/16 to 44 5/8.